(IN BRIEF) Fresenius’ mAbxience has partnered with HP Inc. to co-develop an AI and digital-twin solution that can model and optimise biopharmaceutical manufacturing. The technology uses real plant data to simulate production scenarios, helping increase reliability, stabilise yields and shorten … Read the full press release
Posted in Artificial Intelligence (AI), Business, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged AI collaboration, AI Collaboration Between mAbxience and HP Targets Smarter, Biopharma Innovation, bioprocess optimisation, biosimilars production, cell culture process, digital transformation, digital twin biomanufacturing, Fresenius, FutureFresenius strategy, HP Inc., industrial AI, León Spain, mAbxience, manufacturing efficiency, monoclonal antibodies, More Predictable Bioprocessing
(IN BRIEF) Merck has completed the second phase of its new €29 million Biologics Testing Center in China, adding 1,500 square meters to the facility. This expansion includes the first biosafety laboratories for Merck in the Chinese market, enabling clients … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?